MERCK & CO. INC. (MRK) Stock News
NYSE:MRK - New York Stock Exchange, Inc. - US58933Y1055 - Common Stock - Currency: USD
MRK Latest News, Press Relases and Analysis
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Is MERCK & CO. INC. (NYSE:MRK) a Good Fit for Dividend Investing?
Uncovering Dividend Opportunities with MERCK & CO. INC. (NYSE:MRK).
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?
Let's look at five big pharma companies, GILD, BMY, MRK, ABBV and SNY slated to release their first-quarter 2025 results this week.
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with no new safety concerns.
Mentions: GILD
Gilead Announces Positive Results From Trodelvy-Keytruda Combo Study For Breast Cancer: But Retail’s Unmoved
Triple-negative breast cancer accounts for approximately 15% of all breast cancers and has a higher chance of recurrence.
Tesla, Alphabet highlight earnings rush as tariff fallout drives markets: What to know this week
More than 100 S&P 500 companies are set to report earnings as the market looks to find footing as the fallout from President Trump's tariffs has sent stocks into a tailspin.
Is SoundHound AI a Buy?
The stock has since pulled back, however, amid concerns about a potential economic slowdown spurred by President Trump's tariffs. In light of all this, is SoundHound stock a buy right now? There are good reasons SoundHound has caught the attention of investors.
Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher’s Portfolio
We recently published a list of 10 Value Stocks in Ken Fisher’s Portfolio. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail; that’s the sentiment echoed by billionaire investor Ken Fisher as their […]
Where Are the Millennials? Boomers Now Buy 42% of U.S. Homes With No Change In Sight
Millennials are being priced out of the housing market and replaced by their parents. According to the National Association of Realtors’ 2025 Home Buyers and Sellers Generational Trends Report, 42% of the home sales between July 2023 and July 2024 ...
Is Merck & Co., Inc. (MRK) the Best Large-Cap Value Stock to Buy as the Recession Hits?
We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that equities around the world […]
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: ABBV
Ahead of Merck (MRK) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Merck (MRK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds?
We recently published a list of 11 Best Quality Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where DocGo Inc. (NASDAQ:DCGO) stands against other best quality penny stocks. The quality factor in stocks refers to companies with strong fundamentals, financial stability, and reliable performance, […]
UnitedHealth Loses $120 Billion in Value on Stock's Worst Day Since 1998
UnitedHealth Group stock had one of its worst days ever on Thursday after the healthcare giant unexpectedly cut its profit forecast for the year.
Is Merck & Co., Inc. (MRK) The Dirt Cheap Stock To Invest In Now?
We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and […]
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?
Gilead Sciences' leading HIV business might face a slowdown in 2025, even though a potential approval of lenacapavir would be a significant boost. We recommend investors to wait and watch for now.
Merck (MRK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Merck & Co., Inc. (MRK): Among the Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private […]
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Jazz Pharmaceuticals (NASDAQ:JAZZ) and its peers.
Is PDD Holdings Inc. (PDD) The Dirt Cheap Stock To Invest In Now?
We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where PDD Holdings Inc. (NASDAQ:PDD) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and has […]
Is TotalEnergies SE (TTE) The Dirt Cheap Stock To Invest In Now?
We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where TotalEnergies SE (NYSE:TTE) stands against other dirt cheap stocks to invest in now. Investor’s Guide to Navigating the Volatilitc The stock market has been experiencing volatility and has quickly […]
Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?
At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV prevention, and recent positive estimate revisions.
Is Merck & Co., Inc. (MRK) the Best Pharma Stock to Buy for Long Term Growth?
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best pharma stocks to buy for long term growth. U.S. Pharma Turns to China for Drug Deals With big […]
Is Merck & Co Inc. (NYSE:MRK) the Most Undervalued Quality Stock to Buy Now?
We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co Inc. (NYSE:MRK) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined ‘The Exchange’ […]
Is Wells Fargo & Co. (NYSE:WFC) the Most Undervalued Quality Stock to Buy Now?
We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a look at where Wells Fargo & Co. (NYSE:WFC) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined ‘The Exchange’ […]
Polygon Labs’ Marc Boiron on Unifying Blockchains
Polygon Labs’ product, AggLayer, aims to fix the fragmentation that has slowed growth in assets. Afra Wang meets the man making it happen.
Merck & Co. Inc. (MRK): Among the High Growth Forever Dividend Stocks to Invest In
We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the past two years, largely due to […]
The Zacks Analyst Blog Merck and AbbVie
Merck and AbbVie are included in this Analyst Blog.
Mentions: ABBV
Merck (MRK) Stock Drops Despite Market Gains: Important Facts to Note
The latest trading day saw Merck (MRK) settling at $79.17, representing a -0.01% change from its previous close.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK). Such...
MERCK & CO. INC. (NYSE:MRK) appears to be flying under the radar despite its strong fundamentals.
MERCK & CO. INC. has a stellar value proposition. NYSE:MRK not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point.